Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 1321K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Cosio, B. G. Articles by Barnes, P. J. Search for Related Content PubMed PubMed Citation Articles by Cosio, B. G. Articles by Barnes, P. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Social Bookmarking                            What's this?

Thoracic Medicine, National Heart and Lung Institute, Imperial College, London SW3 6LY, England, UK

Address correspondence to Peter J. Barnes, Thoracic Medicine, National Heart and Lung Institute, Imperial College, Dovehouse St., London SW3 6LY, England, UK. Phone: 44-207-351-8174; Fax: 44-207-351-5675; email: p.j.barnes{at}imperial.ac.uk

Chronic obstructive pulmonary disease (COPD) is a common chronic inflammatory disease of the lungs with little or no response to glucocorticoids and a high level of oxidative stress. Histone deacetylase (HDAC) activity is reduced in cells of cigarette smokers, and low concentrations of theophylline can increase HDAC activity. We measured the effect of theophylline on HDAC activity and inflammatory gene expression in alveolar macrophages (AM) from patients with COPD. AM from normal smokers showed a decrease in HDAC activity compared with normal control subjects, and this was further reduced in COPD patients (51% decrease, P < 0.01). COPD AMs also showed increased basal release of IL-8 and TNF-, which was poorly suppressed by dexamethasone. Theophylline induced a sixfold increase in HDAC activity in COPD AM lysates and significantly enhanced dexamethasone suppression of induced IL-8 release, an effect that was blocked by the HDAC inhibitor trichostatin A. Therefore, theophylline might restore steroid responsiveness in COPD patients.

Key Words: histone deacetylase • theophylline • steroid resistance • COPD • interleukin-8

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

• Barnes, P. J. (2009). Histone deacetylase-2 and airway disease. Ther Adv Respir Dis 3: 235-243 [Abstract]  
• Marti-Lliteras, P., Regueiro, V., Morey, P., Hood, D. W., Saus, C., Sauleda, J., Agusti, A. G. N., Bengoechea, J. A., Garmendia, J. (2009). Nontypeable Haemophilus influenzae Clearance by Alveolar Macrophages Is Impaired by Exposure to Cigarette Smoke. Infect. Immun. 77: 4232-4242 [Abstract] [Full Text]  
• MacNee, W., Tuder, R. M. (2009). New Paradigms in the Pathogenesis of Chronic Obstructive Pulmonary Disease I. Proc Am Thorac Soc 6: 527-531 [Abstract] [Full Text]  
• Kane, B., Kolsum, U., Southworth, T., Armstrong, J., Woodcock, A., Singh, D. (2009). The Effects of Smoking on the Lipopolysaccharide Response and Glucocorticoid Sensitivity of Alveolar Macrophages of Patients With Asthma. Chest 136: 163-170 [Abstract] [Full Text]  
• Bartling, T. R., Drumm, M. L. (2009). Loss of CFTR results in reduction of histone deacetylase 2 in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L35-L43 [Abstract] [Full Text]  
• Spears, M., Donnelly, I., Jolly, L., Brannigan, M., Ito, K., McSharry, C., Lafferty, J., Chaudhuri, R., Braganza, G., Adcock, I. M., Barnes, P. J., Wood, S., Thomson, N. C. (2009). Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study. Eur Respir J 33: 1010-1017 [Abstract] [Full Text]  
• Cosio, B G, Iglesias, A, Rios, A, Noguera, A, Sala, E, Ito, K, Barnes, P J, Agusti, A (2009). Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD. Thorax 64: 424-429 [Abstract] [Full Text]  
• Marwick, J. A., Caramori, G., Stevenson, C. S., Casolari, P., Jazrawi, E., Barnes, P. J., Ito, K., Adcock, I. M., Kirkham, P. A., Papi, A. (2009). Inhibition of PI3K{delta} Restores Glucocorticoid Function in Smoking-induced Airway Inflammation in Mice. Am. J. Respir. Crit. Care Med. 179: 542-548 [Abstract] [Full Text]  
• N'Guessan, P. D., Riediger, F., Vardarova, K., Scharf, S., Eitel, J., Opitz, B., Slevogt, H., Weichert, W., Hocke, A. C., Schmeck, B., Suttorp, N., Hippenstiel, S. (2009). Statins Control Oxidized LDL-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells. Arterioscler. Thromb. Vasc. Bio. 29: 380-386 [Abstract] [Full Text]  
• Pons, D., de Vries, F. R., van den Elsen, P. J., Heijmans, B. T., Quax, P. H.A., Jukema, J. W. (2009). Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. Eur Heart J 30: 266-277 [Abstract] [Full Text]  
• Kent, L. M., Smyth, L. J. C., Plumb, J., Clayton, C. L., Fox, S. M., Ray, D. W., Farrow, S. N., Singh, D. (2009). Inhibition of Lipopolysaccharide-Stimulated Chronic Obstructive Pulmonary Disease Macrophage Inflammatory Gene Expression by Dexamethasone and the p38 Mitogen-Activated Protein Kinase Inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504). J. Pharmacol. Exp. Ther. 328: 458-468 [Abstract] [Full Text]  
• Rahman, I. (2008). Review: Antioxidant therapeutic advances in COPD. Ther Adv Respir Dis 2: 351-374 [Abstract]  
• Barnes, P. J. (2008). Emerging Pharmacotherapies for COPD. Chest 134: 1278-1286 [Abstract] [Full Text]  
• Seemungal, T., Sykes, A., and the ICEAD Contributors, (2008). Recent advances in exacerbations of COPD. Thorax 63: 850-852 [Full Text]  
• Meja, K. K., Rajendrasozhan, S., Adenuga, D., Biswas, S. K., Sundar, I. K., Spooner, G., Marwick, J. A., Chakravarty, P., Fletcher, D., Whittaker, P., Megson, I. L., Kirkham, P. A., Rahman, I. (2008). Curcumin Restores Corticosteroid Function in Monocytes Exposed to Oxidants by Maintaining HDAC2. Am. J. Respir. Cell Mol. Bio. 39: 312-323 [Abstract] [Full Text]  
• Foronjy, R., Nkyimbeng, T., Wallace, A., Thankachen, J., Okada, Y., Lemaitre, V., D'Armiento, J. (2008). Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L1149-L1157 [Abstract] [Full Text]  
• Braganza, G., Chaudhuri, R., Thomson, N. C. (2008). Review: Treating patients with respiratory disease who smoke. Ther Adv Respir Dis 2: 95-107 [Abstract]  
• Facchinetti, F., Amadei, F., Geppetti, P., Tarantini, F., Di Serio, C., Dragotto, A., Gigli, P. M., Catinella, S., Civelli, M., Patacchini, R. (2007). {alpha},beta-Unsaturated Aldehydes in Cigarette Smoke Release Inflammatory Mediators from Human Macrophages. Am. J. Respir. Cell Mol. Bio. 37: 617-623 [Abstract] [Full Text]  
• Grenz, A., Zhang, H., Weingart, J., von Wietersheim, S., Eckle, T., Schnermann, J., Kohle, C., Kloor, D., Gleiter, C. H., Vallon, V., Eltzschig, H. K., Osswald, H. (2007). Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia. Am. J. Physiol. Renal Physiol. 293: F1501-F1511 [Abstract] [Full Text]  
• Li, B., Samanta, A., Song, X., Iacono, K. T., Bembas, K., Tao, R., Basu, S., Riley, J. L., Hancock, W. W., Shen, Y., Saouaf, S. J., Greene, M. I. (2007). FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl. Acad. Sci. USA 104: 4571-4576 [Abstract] [Full Text]  
• Dashwood, R. H. (2006). Xenobiotic Metabolism Relevance to Cancer. J. Nutr. 136: 2681S-2682S [Full Text]  
• Barnes, P J (2006). Theophylline for COPD. Thorax 61: 742-743 [Full Text]  
• Hirano, T, Yamagata, T, Gohda, M, Yamagata, Y, Ichikawa, T, Yanagisawa, S, Ueshima, K, Akamatsu, K, Nakanishi, M, Matsunaga, K, Minakata, Y, Ichinose, M (2006). Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline. Thorax 61: 761-766 [Abstract] [Full Text]  
• Rahman, I., Adcock, I. M. (2006). Oxidative stress and redox regulation of lung inflammation in COPD.. Eur Respir J 28: 219-242 [Abstract] [Full Text]  
• Caramori, G., Papi, A. (2006). Smoking history effect on peripheral lung inflammation and gene transcription in chronic obstructive pulmonary disease.. Am. J. Respir. Crit. Care Med. 174: 2-3 [Full Text]  
• Yang, S.-R., Chida, A. S., Bauter, M. R., Shafiq, N., Seweryniak, K., Maggirwar, S. B., Kilty, I., Rahman, I. (2006). Cigarette smoke induces proinflammatory cytokine release by activation of NF-{kappa}B and posttranslational modifications of histone deacetylase in macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L46-L57 [Abstract] [Full Text]  
• Rodriguez-Roisin, R (2006). COPD exacerbations {middle dot} 5: Management.. Thorax 61: 535-544 [Abstract] [Full Text]  
• Li, L.-b., Leung, D. Y. M., Hall, C. F., Goleva, E. (2006). Divergent expression and function of glucocorticoid receptor {beta} in human monocytes and T cells. J. Leukoc. Biol. 79: 818-827 [Abstract] [Full Text]  
• Barnes, P. J. (2006). Corticosteroid effects on cell signalling. Eur Respir J 27: 413-426 [Abstract] [Full Text]  
• Dashwood, R. H., Myzak, M. C., Ho, E. (2006). Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?. Carcinogenesis 27: 344-349 [Abstract] [Full Text]  
• Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., Adcock, I. M. (2006). Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-{kappa}B suppression. JEM 203: 7-13 [Abstract] [Full Text]  
• Barnes, P. J. (2006). Reduced Histone Deacetylase in COPD: Clinical Implications. Chest 129: 151-155 [Abstract] [Full Text]  
• Donohue, J. F. (2005). Combination Therapy for Chronic Obstructive Pulmonary Disease: Clinical Aspects. Proc Am Thorac Soc 2: 272-281 [Abstract] [Full Text]  
• Barnes, P. J. (2005). Theophylline in Chronic Obstructive Pulmonary Disease: New Horizons. Proc Am Thorac Soc 2: 334-339 [Abstract] [Full Text]  
• Birrell, M. A., Wong, S., Hele, D. J., McCluskie, K., Hardaker, E., Belvisi, M. G. (2005). Steroid-resistant Inflammation in a Rat Model of Chronic Obstructive Pulmonary Disease Is Associated with a Lack of Nuclear Factor-{kappa}B Pathway Activation. Am. J. Respir. Crit. Care Med. 172: 74-84 [Abstract] [Full Text]  
• Barnes, P. J., Stockley, R. A. (2005). COPD: current therapeutic interventions and future approaches. Eur Respir J 25: 1084-1106 [Abstract] [Full Text]  
• Ito, K., Ito, M., Elliott, W. M., Cosio, B., Caramori, G., Kon, O. M., Barczyk, A., Hayashi, S., Adcock, I. M., Hogg, J. C., Barnes, P. J. (2005). Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease. NEJM 352: 1967-1976 [Abstract] [Full Text]  
• Shapiro, S. D. (2005). COPD Unwound. NEJM 352: 2016-2019 [Full Text]  
• Yang, X.-J., Gregoire, S. (2005). Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication. Mol. Cell. Biol. 25: 2873-2884 [Full Text]  
• Barnes, P. J., Adcock, I. M., Ito, K. (2005). Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 25: 552-563 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS